SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIO, Inc. is a holding company which engages in the design, manufacture, and sale of electric vehicles. Its products include the EP9 supercar and ES8 7-seater SUV. It provides users with home charging, power express valet services, and other power solutions including access to public charging, access to power mobile charging trucks, and battery swapping. It also offers other value-added services such as service package, battery payment arrangement, and vehicle financing and license plate registration. The company was founded by Bin Li and Li Hong Qin on November 28, 2014 and is headquartered in Jiading, China.

NIO Inc - ADR

NIO Inc

NIO is trending after announcing record-high vehicle deliveries for December and the fourth quarter, significantly surpassing previous figures and nearing one million cumulative vehicles. This strong performance, further supported by extended EV subsidies in China, is driving considerable community discussion and optimism about the company's path to profitability and its competitive standing in the electric vehicle market.

What is Amp?  Amp is described as the new digital collateral token offering instant, verifiable assurances for any kind of value transfer. Using Amp, networks like Flexa can quickly and irreversibly secure transactions for a wide variety of asset-related use cases.  How does Amp work?  Amp claims to offer a straightforward but versatile interface for verifiable collateralization through a system of collateral partitions and collateral managers. Where collateral partitions can be designated to collateralize any account, application, or even transaction, and carry balances which are directly verifiable on the Ethereum blockchain, collateral managers are smart contracts that can lock, release, and redirect collateral in these partitions as needed in order to support value transfer activities. Amp supports a wide variety of use cases for collateralization, and also introduces the concept of predefined partition strategies, which can enable special capabilities such as collateral models through which tokens can be staked without ever leaving their original address.

AMP Token

AMP Crypto is trending after a recent price surge ignited a polarized community discussion. Supporters emphasize its real-world utility through Flexa's merchant network and anticipate significant growth with pending regulatory clarity and strategic partnerships. However, many investors express deep frustration, warning of sustained manipulation and a history of pump-and-dump cycles despite its technological foundations.

Intelligent Bio Solutions, Inc. is a medical technology company, which engages in delivering testing solutions. It operates through the Intelligent Fingerprinting Products (IFPG) and Saliva Glucose Biosensor Platform (SGBP) segments. It offers biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was founded on December 5, 2016 and is headquartered in New York, NY.

Intelligent Bio Solutions Inc

Intelligent Bio Solutions (INBS) is a hot topic following its announcement of a strategic manufacturing partnership designed to scale production of its fingerprinting drug screening reader and reduce costs. The market is heavily divided, with many anticipating explosive gains due to the stock's low float, while others express significant concern over recent share dilution from a private placement with warrants. This has created extremely volatile trading activity, as bullish momentum traders clash with short-sellers over the stock's immediate future.

Tidal Trust II - Defiance Daily Target 2x Long SMCI ETF

Defiance Daily Target 2X Long SMCI ETF

SMCX is currently trending amidst significant investor confusion and frustration surrounding a recent dividend event and persistent tracking discrepancies with its underlying asset, SMCI. The community is actively questioning the ETF's unusual behavior, with some alleging it's a "scam" or facing an imminent reverse split, while others view the current downturn as a potential buying opportunity despite concerns about leveraged product decay.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is currently a hot topic, with community discussion centering on the ongoing delay and mixed initial data for its inhaled cystic fibrosis therapy, ARCT-032, which showed some mucus plug reduction but not significant lung function improvements. Investors are closely monitoring an active trade secret lawsuit against AbbVie, generating widespread hope for a substantial settlement or potential acquisition. Many believe the company's advanced mRNA platform and solid cash runway make the stock deeply undervalued amidst significant short interest.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc is a key topic as it actively positions itself for the substantial Rural Health Transformation Program, aiming to modernize rural healthcare with its virtual care network and AI-driven solutions. Investors are vocal, with some passionately highlighting the company's global leadership and significant undervaluation, expecting a major turnaround, while others voice deep frustration over past stock performance and current management's perceived shortcomings. Recent discussions also revolve around strategic partnerships, such as the TytoCare integration for at-home care, as potential catalysts.

SpaceX engineers reusable launch vehicles and the Starlink satellite constellation for global broadband. Their focus on rapid reusability and vertical integration drives down launch costs and accelerates space access.

SpaceX PreStocks

Widespread speculation about a potential SpaceX initial public offering is driving significant market conversation and creating considerable buzz within the aerospace sector. This anticipation is fueling active community discussion around related companies positioned as 'SpaceX IPO plays' or partners, notably highlighting firms involved in upcoming Falcon 9 missions. However, alongside the excitement, some investors are raising cautionary flags about speculative mentions and the legitimacy of certain 'SPACEX CRYPTO' references.

Zevra Therapeutics, Inc. is a commercial-stage rare disease company that combines science, data and patient needs to create therapies for diseases with limited or no treatment options. The firm focuses on the treatment of rare neurological and sleep conditions such as certain Urea Cycle Disorders, Niemann Pick Disease Type C and Idiopathic Hypersomnia. The company receives royalties for AZSTARYS from its commercial partner Corium. The company was founded by Christal M. M. Mickle and Travis C. Mickle on October 30, 2006 and is headquartered in Celebration, FL.

Zevra Therapeutics Inc

Zevra Therapeutics is trending amid intense community discussion following recent developments, including a partial summary judgment in its ongoing litigation and strategic changes to its executive team, which are fueling heightened speculation around a potential acquisition. Investors are closely monitoring progress for its rare disease therapy, MIPLYFFA, toward European market access and a patent term extension, while broadly criticizing management for perceived undervaluation and executive compensation. Despite these concerns, many maintain a bullish outlook, citing the company's significant cash reserves and pipeline assets as indicators of untapped value.

Cadrenal Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapy. It develops tecarfarin, a novel therapy with orphan drug indication, designed for the prevention of systemic thromboembolism of cardiac origin in patients with end-stage renal disease and atrial fibrillation. The company was founded by Quang X. Pham and Matthew K. Szot on January 25, 2022 and is headquartered in Ponte Vedra, FL.

Cadrenal Therapeutics Inc

Cadrenal Therapeutics, Inc.

Cadrenal Therapeutics is gaining attention for its expanding anticoagulation pipeline, highlighted by recent acquisitions and significant progress on its lead candidate, tecarfarin, including manufacturing readiness and a collaboration with Abbott. This "quiet expansion" is sparking community interest, with many anticipating a breakout given its low float and regulatory designations. However, skepticism persists among some regarding the company's financial stability and potential dilution.

Polestar Automotive Holding UK Plc is the Swedish electric performance car brand that engages in the research, development, marketing, commercialization, and sales of battery electric vehicles and related technology solutions. It offers Polestar 2 (PS2), a premium fast-back sedan, the Polestar 3 (PS3), a luxury aero sport-utility vehicle, the Polestar 4 (PS4), a premium sport utility vehicle, the Polestar 5 (PS5), a luxury sport grand-touring sedan, and the Polestar 6 (PS6), a luxury roadster. The company was founded on September 15, 2021 and is headquartered in Gothenburg, Sweden.

Polestar Automotive Holding UK PLC - ADR Class A

Polestar is a hot topic following a substantial $600 million financing boost and the looming 1-for-30 reverse stock split, which has sparked intense debate among investors. While many are optimistic about strong Q4 delivery numbers for the Polestar 4 and new Google Gemini AI integration, community sentiment remains sharply divided on whether operational improvements can finally overcome persistent skepticism about the stock's performance.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Autodesk, Inc. (ADSK) stock received a price target boost after the engineering design software maker announced a first-quarter beat.Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating, The Fly reported. The analysts called the results “solid” and expressed comfort at the company reiterating its guidance in a&nbsp;challenging macro/industrial backdrop.The research firm said the company embedded incremental macro conservatism in the guidance even as it flagged no material change in demand through May.Autodesk’s key quarterly metrics for the first quarter of the fiscal year 2026 are as follows:<ul><li>Adj. earnings per share (EPS): $2.29 Vs. $2.15 consensus</li><li>Revenue: $1.63B (up 15% YoY) Vs. $1.61B consensus</li><li>Billings: $1.43B (up 29% YoY)</li></ul>&nbsp;"Q1 was another strong quarter. We have not seen changes in overall business momentum when compared to recent quarters," said Janesh Moorjani, Autodesk CFO.The executive said the guidance for the second quarter and the rest of the fiscal year included currency movements since February, partly offset by additional caution in growth assumptions reflecting greater macroeconomic uncertainty.Autodesk guided second-quarter adjusted EPS and revenue to a range of $2.44-$2.48 and $1.72 billion-$1.73 billion, respectively. Analysts, on average, estimate $2.39 and $1.71 billion, respectively.On Stocktwits, retail sentiment toward Autodesk stock was ‘extremely bullish’ (90/100) by late Thursday, with the message volume at ‘extremely high’ levels.<figure class="image"><img style="aspect-ratio:618/51;" src="https://news.stocktwits-cdn.com/Screenshot_2025_05_23_at_3_51_37_AM_png_9f2ad510f9.webp" alt="Screenshot 2025-05-23 at 3.51.37 AM.png" width="618" height="51"><figcaption>ADSK sentiment and message volume as of 3:52 a.m. ET, May 23 | source: Stocktwits</figcaption></figure>A bullish user said Autodesk had a much better earnings report and forecast&nbsp;than Snowflake, Inc. (SNOW). While noting that Snowflake went up by 13.4% on Thursday, they predicted Autodesk stock&nbsp;would hit&nbsp;$334 on Friday.<stembedurl>https://stocktwits.com/AIIAAIIA_88/message/615613366</stembedurl>Another user feared the guidance could bring the stock down, but expressed faith that it&nbsp;would go up in the long run.<stembedurl>https://stocktwits.com/nj8263/message/615611228</stembedurl><a href="https://stocktwits.com/symbol/ADSK">Autodesk stock </a>rose 3.32% to $304.78 in the after-hours session, but it is down marginally for the year. During the quarter, the company faced a proxy war from activist investor Starboard over the stock's underperformance.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/apple-retail-traders-lose-faith-amid-7-day-losing-streak/ch0Q9ynRbqh">Apple Retail Traders Lose Faith As Market-Cap Trails Microsoft, Nvidia Amid 7-Day Losing Streak</a>

In this photo illustration, the Autodesk Software company logo seen displayed on a smartphone.

Autodesk Shrugs Off Macro Vagaries After Q1 Beat: Analysts, Retail Turn Stick To Bullish Stances

Following Q1 results, Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating.

Equity

Following Q1 results, Oppenheimer analysts upped their price target for the Autodesk stock to $350 from $300 and maintained an ‘Outperform’ rating.


Autodesk, Inc. (ADSK) shares climbed on Wednesday after activist investor Starboard confirmed a proxy war against the design software maker. Responding to Starboard’s publicly released letter, the company said it would review the rival slate of directors if it goes ahead with director nominations.In a statement released after the market&nbsp;closed, San Francisco, California-based Autodesk confirmed the receipt of Starboard’s letter.&nbsp;The company said if Starboard proceeds with its nomination, the board’s Corporate Governance Committee will review its candidates as part of the regular director evaluation process. It also asked its shareholders not to take any action at this time.Starboard’s stake in Autodesk is currently valued at over $500 million.The company also clarified that the activist investor did not take any action last year when it offered an opportunity to participate in the new director election process. It also noted that it proactively met with Starwood representatives repeatedly last year, inviting them to present ideas to the full board.Meanwhile, in the letter signed by Managing Member Jeffrey Smith, Starboard took exception to Autodesk’s decision to offer clarity on the impact of the recently announced job cuts at the Investor Day to be held in the third quarter. It added that the event would come well after the annual shareholder meeting.&nbsp;The activist investor claimed in the letter that there is a substantial margin improvement opportunity at Autodesk. The firm said the fiscal year 2026 guidance does not make sense in light of the 9% workforce reduction recently and that the company should shoot for 45% adjusted operating margins by the fiscal year 2028.Starboard also called for board changes to ensure accountability for value creation.Replying to issues raised by Starboard, Autodesk said it has been taking decisive actions to drive growth, significantly expand operating margin, generate robust cash flow and continue innovating for customers.The company also said it has a proven track record of board refreshment and strong corporate governance.<figure class="image"><img style="aspect-ratio:632/132;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/adsk_sentiment_png_10ad23a60d.webp" alt="adsk-sentiment.png" width="632" height="132"><figcaption>ADSK sentiment and message volume March 20, as of 2:20 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward&nbsp;<a href="https://stocktwits.com/symbol/ADSK">Autodesk stock</a> reverted to ‘bearish’ by the end of Wednesday’s session from the ‘neutral’ mood that prevailed a day ago. The message volume was ‘low.’Autodesk ended Wednesday’s session up 3.21%at $268.30. The stock has lost about 10% so far this year.For updates and corrections email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/crowdstrike-unfazed-by-alphabet-s-wiz-buy/ch7NW7cRb2w">CrowdStrike Analyst Dismisses Alphabet-Wiz Threat, But Retail Sees Some Risks</a>

Autodesk Says Willing To Review Starboard Slate As Proxy War Heats Up: Retail Mood Worsens

Replying to issues raised by Starboard, Autodesk said it has been taking decisive actions to drive growth, significantly expand operating margin, generate robust cash flow and continue innovating for customers.

Shares of engineering design software maker Autodesk, Inc. (ADSK) could see some activity on Wednesday after a report said activist investor Starboard, citing stock underperformance, was prepared for a proxy war with the company.Over the past year, Autodesk stock underperformed the broader market and the tech sector.&nbsp;&nbsp;<figure class="image"><img style="aspect-ratio:1534/529;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/ADSK_2025_03_19_03_43_16_png_ff44dab84f.webp" alt="ADSK_2025-03-19_03-43-16.png" width="1534" height="529"><figcaption>Chart Courtesy of TradingView</figcaption></figure>An exclusive Wall Street Journal report<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.wsj.com/tech/activist-starboard-prepares-to-launch-proxy-fight-at-autodesk-524c0443">&nbsp;said</a>&nbsp;Starboard, led by CEO Jeff Smith, was looking to nominate a minority slate of director candidates ahead of Autodesk’s annual shareholders’ meeting.The report noted that Starboard failed last year to block a board meeting after failing to nominate directors by the March deadline.&nbsp;After the Journal disclosed a Starboard stake in Autodesk last summer, the activist investor said it wanted the company to reassess its longtime CEO, Andrew Anagnost.Autodesk stock is trading well off its Aug. 2021 all-time high of $344.39. A delay in filing the annual report for the year ended Jan. 2024 and disclosure regarding the investigation into its accounting practices dragged the stock lower last year. The stock bottomed at $189.54 in early May.The weakness continued this year despite Autodesk reporting<a href="https://stocktwits.com/news-articles/markets/equity/autodesk-stock-volatile-after-hours-after-2025-q4-results/chdg9xwRyp">&nbsp;better-than-expected fourth-quarter results</a> in late February and issuing above-consensus guidance. The company also announced optimization initiatives, including job cuts to reallocate resources to critical areas such as artificial intelligence (AI).<figure class="image"><img style="aspect-ratio:632/136;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/adsk_sentiment_png_a890e7207c.webp" alt="adsk-sentiment.png" width="632" height="136"><figcaption>ADSK sentiment and message volume March 19, as of 4:51 am ET | Source:&nbsp;Stocktwits</figcaption></figure>On Stocktwits, retail sentiment toward<a href="https://stocktwits.com/symbol/ADSK"> Autodesk stock</a>&nbsp;remained ‘neutral’, and the message volume stayed ‘extremely low.’Autodesk stock has declined over 12% this year and traded in a 52-week range of $195.32-$326.52.For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/servicenow-salesforce-cadence-design-beaten-down-sp-500-application-software-stocks/ch7kXV9Rb2O">ServiceNow, Salesforce And Cadence Design: How Retail’s Positioned On These Beaten-Down S&amp;P 500 Application Software Stocks</a>

Autodesk Activist Drama Unfolds As Starboard Reportedly Gears Up For Proxy Fight: Retail Traders Divided

Starboard is reportedly considering nominating a minority slate of director candidates ahead of Autodesk’s annual shareholders’ meeting.

Current Price	$26.04
Prev Close	$26.28
Open	$26.35
Dividend Yield	N/A
50-Day Moving Average	$26.66
Beta	N/A
Avg. Volume	939.11
PE Ratio	N/A

52-Week High	$28.96
52-Week Low	$17.64
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

BULD
Pacer Funds Trust - Pacer BlueStar Engineering the Future ETF

Feed

News

Sentiment

Fundamentals

Info

Latest BULD News

BULDPacer Funds Trust - Pacer BlueStar Engineering the Future ETF